Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 7, pp. 914-922
Open Access | Times Cited: 593

Showing 1-25 of 593 citing articles:

Cancer statistics, 2020
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 1, pp. 7-30
Open Access | Times Cited: 18513
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 10, pp. 1309-1316
Open Access | Times Cited: 569
Update 2020: Management of Non-Small Cell Lung Cancer
Mariam Alexander, So Yeon Kim, Haiying Cheng
Lung (2020) Vol. 198, Iss. 6, pp. 897-907
Open Access | Times Cited: 452
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
Eugene Merzon, Dmitry Tworowski, Alessandro Gorohovski, et al.
FEBS Journal (2020) Vol. 287, Iss. 17, pp. 3693-3702
Open Access | Times Cited: 406
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1319-1368
Open Access | Times Cited: 361
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (2020) Vol. 139, pp. 43-50
Open Access | Times Cited: 318
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper, et al.
Annals of Oncology (2021) Vol. 32, Iss. 6, pp. 787-800
Open Access | Times Cited: 294
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 257
COVID-19 in cancer patients: risk, clinical features, and management
Cuiwei Liu, Yanxia Zhao, Derick Okwan‐Duodu, et al.
Cancer Biology and Medicine (2020) Vol. 17, Iss. 3, pp. 519-527
Open Access | Times Cited: 216
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Cancer Discovery (2020) Vol. 11, Iss. 2, pp. 233-236
Open Access | Times Cited: 205
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis
Hua Zhang, Han Han, Tianhui He, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 4, pp. 371-380
Open Access | Times Cited: 193
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
Mariana Chávez‐MacGregor, Xiudong Lei, Hui Zhao, et al.
JAMA Oncology (2021) Vol. 8, Iss. 1, pp. 69-69
Open Access | Times Cited: 193
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2021) Vol. 78, Iss. 7, pp. e170-e207
Open Access | Times Cited: 175
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 161
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard, et al.
European Journal of Cancer (2020) Vol. 141, pp. 62-81
Open Access | Times Cited: 152
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 151
Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 12, pp. 2042-2057
Open Access | Times Cited: 140
COVID-19 and its cardiovascular effects: a systematic review of prevalence studies
Pierpaolo Pellicori, Gemina Doolub, Chih Wong, et al.
Cochrane library (2021) Vol. 2022, Iss. 4
Open Access | Times Cited: 129
Severity of COVID-19 in patients with lung cancer: evidence and challenges
Antonio Passaro, Christine M. Bestvina, Maria Velez Velez, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e002266-e002266
Open Access | Times Cited: 121
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Joyce K. Hwang, Tian Zhang, Andrew Z. Wang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 120
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
David J. Pinato, Josep Tabernero, Mark Bower, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 12, pp. 1669-1680
Open Access | Times Cited: 111
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
Andrea Becerril‐Gaitan, Bryan F. Vaca‐Cartagena, Ana S. Ferrigno, et al.
European Journal of Cancer (2021) Vol. 160, pp. 243-260
Open Access | Times Cited: 106
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 74
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
David J. Pinato, Juan Aguilar‐Company, Daniela Ferrante, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 7, pp. 865-875
Open Access | Times Cited: 69
Prevalence and risk factors for long COVID among cancer patients: a systematic review and meta-analysis
Hongkun Xu, Tingting Lu, Yajie Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top